Cargando…

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

Detalles Bibliográficos
Autores principales: Skyler, Jay S., Bergenstal, Richard, Bonow, Robert O., Buse, John, Deedwania, Prakash, Gale, Edwin A.M., Howard, Barbara V., Kirkman, M. Sue, Kosiborod, Mikhail, Reaven, Peter, Sherwin, Robert S.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606812/
https://www.ncbi.nlm.nih.gov/pubmed/19092168
http://dx.doi.org/10.2337/dc08-9026
_version_ 1782162987290722304
author Skyler, Jay S.
Bergenstal, Richard
Bonow, Robert O.
Buse, John
Deedwania, Prakash
Gale, Edwin A.M.
Howard, Barbara V.
Kirkman, M. Sue
Kosiborod, Mikhail
Reaven, Peter
Sherwin, Robert S.
author_facet Skyler, Jay S.
Bergenstal, Richard
Bonow, Robert O.
Buse, John
Deedwania, Prakash
Gale, Edwin A.M.
Howard, Barbara V.
Kirkman, M. Sue
Kosiborod, Mikhail
Reaven, Peter
Sherwin, Robert S.
author_sort Skyler, Jay S.
collection PubMed
description
format Text
id pubmed-2606812
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-26068122010-01-01 Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Skyler, Jay S. Bergenstal, Richard Bonow, Robert O. Buse, John Deedwania, Prakash Gale, Edwin A.M. Howard, Barbara V. Kirkman, M. Sue Kosiborod, Mikhail Reaven, Peter Sherwin, Robert S. Diabetes Care Reviews/Commentaries/ADA Statements American Diabetes Association 2009-01 /pmc/articles/PMC2606812/ /pubmed/19092168 http://dx.doi.org/10.2337/dc08-9026 Text en Copyright © 2009, American Diabetes Association https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Reviews/Commentaries/ADA Statements
Skyler, Jay S.
Bergenstal, Richard
Bonow, Robert O.
Buse, John
Deedwania, Prakash
Gale, Edwin A.M.
Howard, Barbara V.
Kirkman, M. Sue
Kosiborod, Mikhail
Reaven, Peter
Sherwin, Robert S.
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title_full Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title_fullStr Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title_full_unstemmed Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title_short Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
title_sort intensive glycemic control and the prevention of cardiovascular events: implications of the accord, advance, and va diabetes trials: a position statement of the american diabetes association and a scientific statement of the american college of cardiology foundation and the american heart association
topic Reviews/Commentaries/ADA Statements
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606812/
https://www.ncbi.nlm.nih.gov/pubmed/19092168
http://dx.doi.org/10.2337/dc08-9026
work_keys_str_mv AT skylerjays intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT bergenstalrichard intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT bonowroberto intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT busejohn intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT deedwaniaprakash intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT galeedwinam intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT howardbarbarav intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT kirkmanmsue intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT kosiborodmikhail intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT reavenpeter intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio
AT sherwinroberts intensiveglycemiccontrolandthepreventionofcardiovasculareventsimplicationsoftheaccordadvanceandvadiabetestrialsapositionstatementoftheamericandiabetesassociationandascientificstatementoftheamericancollegeofcardiologyfoundationandtheamericanheartassociatio